Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00715_DB01624> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00715_DB01624 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00715_DB01624 label "DDI between Paroxetine and Zuclopenthixol - Paroxetine, a strong CYP2D6 inhibitor, may increase the serum concentration of zuclopenthixol by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of zuclopenthixol if paroxetine is initiated, discontinued or dose changed. [drugbank_resource:DB00715_DB01624]" assertion.
- drugbank_resource:DB00715_DB01624 identifier "drugbank_resource:DB00715_DB01624" assertion.
- drugbank_resource:DB00715_DB01624 title "DDI between Paroxetine and Zuclopenthixol - Paroxetine, a strong CYP2D6 inhibitor, may increase the serum concentration of zuclopenthixol by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of zuclopenthixol if paroxetine is initiated, discontinued or dose changed." assertion.